Literature DB >> 7698313

Alterations in the internucleosomal DNA helical twist in chromatin of human erythroleukemia cells in vivo influences the chromatin higher-order folding.

W A Krajewski1.   

Abstract

In the present study chloroquine diphosphate, a DNA intercalating drug, was used to alter the internucleosomal DNA helical twist in chromatin of living mammalian cells. The intercalative binding of chloroquine effectively unwinds the DNA double helix and its binding is restricted to nucleosomal linker regions without noticeable disruption of nucleosomes. The results presented here imply that the alterations in the rotation angle between the adjacent nucleosomes in chromatin of eukaryotic cells in vivo significantly influences the way the chain of nucleosomes folds in higher-order chromatin structures, as evidenced by specific alterations in nuclease susceptibility of chromatin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7698313     DOI: 10.1016/0014-5793(95)00144-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Synthesis, characterization and biological activity of trans-platinum(II) complexes with chloroquine.

Authors:  Maribel Navarro; William Castro; Angel R Higuera-Padilla; Anibal Sierraalta; María Jesús Abad; Peter Taylor; Roberto A Sánchez-Delgado
Journal:  J Inorg Biochem       Date:  2011-09-22       Impact factor: 4.155

2.  Internal structure and dynamics of isolated Escherichia coli nucleoids assessed by fluorescence correlation spectroscopy.

Authors:  Tatyana Romantsov; Itzhak Fishov; Oleg Krichevsky
Journal:  Biophys J       Date:  2007-01-26       Impact factor: 4.033

3.  Modulation of the higher-order folding of chromatin by deletion of histone H3 and H4 terminal domains.

Authors:  W A Krajewski; J Ausió
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

4.  Chloroquine improves survival and hematopoietic recovery after lethal low-dose-rate radiation.

Authors:  Yiting Lim; Mohammad Hedayati; Akil A Merchant; Yonggang Zhang; Hsiang-Hsuan M Yu; Michael B Kastan; William Matsui; Theodore L Deweese
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-22       Impact factor: 7.038

5.  The mechanism of antimalarial action of [Au(CQ)(PPh(3))]PF(6): structural effects and increased drug lipophilicity enhance heme aggregation inhibition at lipid/water interfaces.

Authors:  Maribel Navarro; William Castro; Alberto Martínez; Roberto A Sánchez Delgado
Journal:  J Inorg Biochem       Date:  2010-11-13       Impact factor: 4.155

6.  The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair.

Authors:  Diana H Liang; Dong Soon Choi; Joe E Ensor; Benny A Kaipparettu; Barbara L Bass; Jenny C Chang
Journal:  Cancer Lett       Date:  2016-04-06       Impact factor: 8.679

Review 7.  Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.

Authors:  Domenico Plantone; Tatiana Koudriavtseva
Journal:  Clin Drug Investig       Date:  2018-08       Impact factor: 3.580

8.  Retrieving the intracellular topology from multi-scale protein mobility mapping in living cells.

Authors:  Michael Baum; Fabian Erdel; Malte Wachsmuth; Karsten Rippe
Journal:  Nat Commun       Date:  2014-07-24       Impact factor: 14.919

9.  Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo.

Authors:  Tao Hu; Pei Li; Zhongguang Luo; Xiaoyu Chen; Jingyang Zhang; Chunyao Wang; Ping Chen; Ziming Dong
Journal:  Oncol Rep       Date:  2015-11-02       Impact factor: 3.906

10.  Boosting ATM activity alleviates aging and extends lifespan in a mouse model of progeria.

Authors:  Minxian Qian; Zuojun Liu; Linyuan Peng; Xiaolong Tang; Fanbiao Meng; Ying Ao; Mingyan Zhou; Ming Wang; Xinyue Cao; Baoming Qin; Zimei Wang; Zhongjun Zhou; Guangming Wang; Zhengliang Gao; Jun Xu; Baohua Liu
Journal:  Elife       Date:  2018-05-02       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.